Locations
San Francisco, CA, USA · North America
industry
Biotechnology · Data and Analytics · DeepTech · Health
Size
51-200 employees
Stage
Other
founded in
2014
Mission Bio is a biotechnology company that specializes in single-cell technology, offering the Tapestri Platform, which is the first and only single-cell multi-omics platform. This platform enables researchers to simultaneously measure single nucleotide variation (SNV), copy number variation (CNV), and protein data from the same cells, providing critical insights into cancer research and treatment. Mission Bio differentiates itself through its comprehensive end-to-end workflow that connects genotype and phenotype, allowing for precise detection of heterogeneity in disease progression and treatment response. The company is positioned in the oncology and precision medicine markets, focusing on applications such as multiple myeloma, AML MRD, and genome editing validation, and has established partnerships with top researchers to enhance its offerings.
Something looks off?